CDH12 plays an important role in non-small-cell lung cancer(NSCLC) geneses, resulting from that the mutations of CDH12 and other PRAME family members were equally distributed among tumors of different grades and stages (Bankovic et al., 2010). The gene discussed is PRAME; the disease is non-small cell lung carcinoma.